Novavax, Inc(NASDAQ:NVAX) 
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one...
Website: http://www.novavax.com
Founded: 1987
Full Time Employees: 522
CEO: Stanley C. Erck
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 5.40
H 6.32
L 5.33
C 6.24
V 9,187,350
10EMA 6.24
20EMA 6.24
60EMA 6.24
120EMA 6.24
250EMA 6.24